n recent years, with China's population growth, aging accelerated, health care reform policies come forth, the medical health sector has become the industry favored by the capital. With BAT and other Internet giants have entered the huge investment Lilac Garden, rain mobile health and medical Internet plus project attracted the attention of many people.
But in fact, in addition to the public more familiar with the Internet related medical field, as the cornerstone of the medical and health industry bio pharmaceutical technology and products, is also a hot pursuit of many wind investment projects. With sophisticated technology, these projects often have higher capital requirements, and once successful listing, and its return is also very rich.
High end technology research capital requirements
The influx of domestic capital into the field of medical health is not new, but as the level of domestic research continues to rise, the demand for funds in the field of high-end technology is bringing more and more investment opportunities. For example, accurate medical field, cancer drugs, blood system diseases drugs may be a breakthrough in bio technology in the future, 3D printing and other interdisciplinary technology have great imagination, has received intensive attention to capital.
The day before the seventh session held Chinese medical industry forum, deputy chief engineer Cheng Gang said David gene, the healthcare industry has a research on high technology, high dependence on talent, need high capital investment. At present, the domestic pharmaceutical industry is highly fragmented, the official statistics of 3.1 enterprises, but the total value is still not comparable to the market value of Merck, a company. This also means that the domestic pharmaceutical industry huge space, enterprises in the future through rapid growth and mergers and acquisitions integration, occupy a greater market share opportunities.